151 related articles for article (PubMed ID: 36111027)
1. MALT1 serves as a biomarker for estimating disease risk of lupus nephritis: a prospective case-control study.
Wang M; Huang L; Peng L; Yang Y; Mao J; Zhu N; Wu B
Ann Transl Med; 2022 Aug; 10(16):874. PubMed ID: 36111027
[TBL] [Abstract][Full Text] [Related]
2. Urinary ferritin creatinine ratio, a potential biomarker for lupus nephritis activity.
Qi L; Xu J; Yang C; Hou X; Yang P
Clin Rheumatol; 2021 Jan; 40(1):143-149. PubMed ID: 32557256
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor binding protein-2 as a novel biomarker for disease activity and renal pathology changes in lupus nephritis.
Ding H; Kharboutli M; Saxena R; Wu T
Clin Exp Immunol; 2016 Apr; 184(1):11-8. PubMed ID: 26616478
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and depression prevalence and their risk factors in lupus nephritis patients: A case-control study.
Hu Y; Zhan G
Immun Inflamm Dis; 2022 Sep; 10(9):e689. PubMed ID: 36039650
[TBL] [Abstract][Full Text] [Related]
5. MALT1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
[TBL] [Abstract][Full Text] [Related]
6. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
7. Serum Levels of Transforming Growth Factor Beta -1 (TGF-β1) as An Early No Invasive Marker for Diagnosis of Lupus Nephritis in Systemic Lupus Erythematosus Patients.
Rashad NM; El-Shabrawy RM; Said D; El-Shabrawy SM; Emad G
Egypt J Immunol; 2019 Jan; 26(1):31-42. PubMed ID: 31332994
[TBL] [Abstract][Full Text] [Related]
8. Proteinuria and serum creatinine after 12 months of treatment for lupus nephritis as predictors of long-term renal outcome: a case-control study.
Braga FNHF; das Chagas Medeiros MM; Junior ABV; de Sousa Lima ME; Barros LCM; Pontes MX; de Sousa Lima AW; Fernandes PFCBC
Adv Rheumatol; 2022 Jan; 62(1):2. PubMed ID: 34983697
[TBL] [Abstract][Full Text] [Related]
9. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus.
Hafez EA; Hassan SAE; Teama MAM; Badr FM
Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012
[TBL] [Abstract][Full Text] [Related]
10. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.
Wu Z; Bi Y
J Clin Lab Anal; 2022 Feb; 36(2):e24130. PubMed ID: 34997981
[TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical and laboratory characteristics and pathology of lupus nephritis-based on 710 renal biopsies in China.
Song K; Liu X; Liu J; Yin Z; Chen P; Cai G; Chen X
Clin Rheumatol; 2020 Nov; 39(11):3353-3363. PubMed ID: 32435895
[TBL] [Abstract][Full Text] [Related]
12. Using plasma circRNA_002453 as a novel biomarker in the diagnosis of lupus nephritis.
Ouyang Q; Huang Q; Jiang Z; Zhao J; Shi GP; Yang M
Mol Immunol; 2018 Sep; 101():531-538. PubMed ID: 30172209
[TBL] [Abstract][Full Text] [Related]
13. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
14. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation.
Liu L; Gao Y; Si Y; Liu B; Liu X; Li G; Wang R
J Clin Lab Anal; 2022 May; 36(5):e24379. PubMed ID: 35353938
[TBL] [Abstract][Full Text] [Related]
15. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis.
Abdul-Maksoud RS; Rashad NM; Elsayed WSH; Ali MA; Kamal NM; Zidan HE
J Gene Med; 2021 May; 23(5):e3326. PubMed ID: 33617143
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of clinical and pathomorphological features of lupus nephritis in children.
Szymanik-Grzelak H; Barabasz M; Wikiera-Magott I; Banaszak B; Wieczorkiewicz-Płaza A; Bieniaś B; Drożynska-Duklas M; Tkaczyk M; Pańczyk-Tomaszewska M
Adv Med Sci; 2021 Mar; 66(1):128-137. PubMed ID: 33545446
[TBL] [Abstract][Full Text] [Related]
18. Human Epididymis Protein 4: A Novel Biomarker for Lupus Nephritis and Chronic Kidney Disease in Systemic Lupus Erythematosus.
Yang Z; Zhang Z; Qin B; Wu P; Zhong R; Zhou L; Liang Y
J Clin Lab Anal; 2016 Nov; 30(6):897-904. PubMed ID: 27075413
[TBL] [Abstract][Full Text] [Related]
19. Serum Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Disease Activity in Lupus Nephritis.
Ghazali WSW; Iberahim R; Ashari NSM
Malays J Med Sci; 2017 Oct; 24(5):62-72. PubMed ID: 29386973
[TBL] [Abstract][Full Text] [Related]
20. Plasma immunoglobulin binding protein 1 as a predictor of development of lupus nephritis.
Kwon OC; Lee EJ; Oh JS; Hong S; Lee CK; Yoo B; Park MC; Kim YG
Lupus; 2020 May; 29(6):547-553. PubMed ID: 32183589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
